Other

Deferred Taxes

Amgen Deferred Taxes decreased by 1.6% to $1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.0%, from $1.51B to $1.34B. Over 3 years (FY 2022 to FY 2025), Deferred Taxes shows an upward trend with a 398.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2019
Last reportedQ1 2026Apr 30, 2026

How to read this metric

An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.

Detailed definition

This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...

Peer comparison

Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.

Metric ID: other_deferred_income_tax_liabilities_net

Historical Data

11 periods
 Q4 '22Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$11.00M$2.35B$1.86B$1.78B$1.71B$1.62B$1.51B$1.39B$1.46B$1.37B$1.34B
QoQ Change>999%-20.9%-4.4%-3.9%-5.6%-6.6%-8.2%+5.2%-6.3%-1.6%
YoY Change>999%-31.4%-18.9%-22.1%-14.8%-15.5%-11.0%
Range$11.00M$2.35B
CAGR+583.6%
Avg YoY Growth>999%
Median YoY Growth-15.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is Amgen's deferred taxes?
Amgen (AMGN) reported deferred taxes of $1.34B in Q1 2026.
How has Amgen's deferred taxes changed year-over-year?
Amgen's deferred taxes decreased by 11.0% year-over-year, from $1.51B to $1.34B.
What is the long-term trend for Amgen's deferred taxes?
Over 3 years (2022 to 2025), Amgen's deferred taxes has grown at a 398.9% compound annual growth rate (CAGR), from $11.00M to $1.37B.
What does deferred taxes mean?
Future tax payments the company expects to make due to timing differences in accounting.